Success Stories: EB-1A Approval for a Visiting Fellow in the field of Bioorganic and Organic Chemistry in Maryland
Client’s Testimonial:
Thank you for helping me with my I-140 approval.
General Field: Bioorganic and Organic Chemistry
Position at the Time of Case Filing: Visiting Fellow
National Origin: India
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Maryland
Approval Notice Date: March 5, 2014
Processing Time: 3 months, 25 days
Case Summary:
The client that we had the privilege of working with in this case was a Visiting Fellow from India in the field of bioorganic and organic chemistry. His work had primarily focused on pharmaceutical research. His results had developed new drug candidates for deadly diseases like HIV/AIDS and had also provided other researchers with very valuable information about biological processes involved in drug design such as sequence selective RNA binders (antibiotics). His work had resulted in at least 16 peer-reviewed scientific articles and, at the time that his case was filed, his publications been cited at least 138 times by researchers around the world, clearly demonstrating that he had influenced his field and garnered international acclaim. In addition, he had reviewed at least 13 papers for journals related to his field by the time we filed his case. Of his accomplishments, one of his recommenders testified, “[He] provided a novel solution to the issue of molecular recognition of such structures; often, these non-coding RNAs are in a double helical conformation, making them difficult to detect. He co-invented a short synthetic peptide known as a Peptide Nucleic Acid (PNA) containing a 2-aminopyridine monomer that can recognize guanosine purine selectively, which can be otherwise difficult to detect. The excellent performance of his PNAs provided an efficient solution to the problem of non-coding RNA detection.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of bioorganic and organic chemistry, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in less than 4 months.